The new discovery advances efforts to find new and effective treatments for heart failure. When heart muscle is damaged, the body is unable to repair the dead or injured cells, researchers said.
Scientists at the Gladstone Institutes in the US are exploring cellular reprogramming - turning one type of adult cell into another - in the heart as a way to regenerate muscle cells in the hopes of treating and ultimately curing, heart failure.
After a heart attack, connective tissue forms scar tissue at the site of the injury, contributing to heart failure.
The three factors, Gata4, Mef2c, and Tbx5 (GMT), work together to turn heart genes on in these cells and turn other genes off, effectively regenerating a damaged heart with its own cells.
However, the method is not foolproof - typically, only ten per cent of cells fully convert from scar tissue to muscle.
The chemicals sped up the process of cell conversion, achieving in one week what used to take six to eight weeks.
"While our original process for direct cardiac reprogramming with GMT has been promising, it could be more efficient," said Deepak Srivastava, director of the Gladstone Institute of Cardiovascular Disease.
"With our screen, we discovered that chemically inhibiting two biological pathways active in embryonic formation improves the speed, quantity, and quality of the heart cells produced from our original process," said Srivastava.
By combining the two chemicals with GMT, the researchers successfully regenerated heart muscle and greatly improved heart function in mice that had suffered a heart attack.
The scientists also used the chemicals to improve direct cardiac reprogramming of human cells, which is a more complicated process that requires additional factors.
The two chemicals enabled the researchers to simplify the process bringing them one step closer to better treatments for heart failure.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
